Rajiv Panwar, Ph.D.
|2012||Pharmaceutics and Drug Delivery Systems||Northeastern University, Boston, MA, United States|
Area:Pharmacy, Polymer Chemistry
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Panwar R, Bhattarai P, Patil V, et al. (2018) Imaging doxorubicin and polymer-drug conjugates of doxorubicin-induced cardiotoxicity with bispecific anti-myosin-anti-DTPA antibody and Tc-99m-labeled polymers. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|
|Khaw BA, Gada KS, Patil V, et al. (2014) Bispecific antibody complex pre-targeting and targeted delivery of polymer drug conjugates for imaging and therapy in dual human mammary cancer xenografts: targeted polymer drug conjugates for cancer diagnosis and therapy. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1603-16|
|Patil V, Gada K, Panwar R, et al. (2013) In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates. Journal of Drug Targeting. 21: 1012-21|
|Gada KS, Patil V, Panwar R, et al. (2012) Bispecific antibody complex pre-targeted delivery of polymer-drug conjugates for cancer therapy. Drug Delivery and Translational Research. 2: 65-76|
|Patil V, Gada K, Panwar R, et al. (2012) Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates. European Journal of Nuclear Medicine and Molecular Imaging. 39: 824-39|
|Gada KS, Patil V, Panwar R, et al. (2011) Pretargeted gamma imaging of murine metastatic melanoma lung lesions with bispecific antibody and radiolabeled polymer drug conjugates. Nuclear Medicine Communications. 32: 1231-40|